Mark S. Warren
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
- Endocrinology top 5%
Papers in
-
- Biochemical and Molecular Research 8
-
- Enzyme Structure and Function 12
- Co-authors
- Olga Lomovskaya (8 shared papers)Hiroko Ishida (3 shared papers)Kazuki Hoshino (3 shared papers)Suzanne Chamberland (3 shared papers)Elizabeth E. Howell (7 shared papers)Ving J. Lee (2 shared papers)Anita R. Mistry (4 shared papers)Stephen J. Benkovic (9 shared papers)
- Journals
- Biochemistry (7 papers)Bioorganic & Medicinal Chemistry (6 papers)Antimicrobial Agents and Chemotherapy (4 papers)Drug Metabolism and Disposition (2 papers)Molecular Microbiology (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
Mark S. Warren
34 papers receiving 2.3k citations
Mark S. Warren's Hit Papers
Peers
Comparison fields: 5 of 101
- Molecular Medicine 1.0k
- Endocrinology 162
- Pharmacology 447
- Applied Microbiology and Biotechnology 41
- Molecular Biology 1.3k
Countries citing papers authored by Mark S. Warren
This map shows the geographic impact of Mark S. Warren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Warren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Warren more than expected).
Fields of papers citing papers by Mark S. Warren
This network shows the impact of papers produced by Mark S. Warren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Warren. The network helps show where Mark S. Warren may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark S. Warren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa : Novel Agents for Combination Therapy Hit paper breakdown → | 2001 | 731 |
| 2 | 1986 | 204 | |
| 3 | 2009 | 191 | |
| 4 | 2000 | 190 | |
| 5 | 1999 | 176 | |
| 6 | 2012 | 105 | |
| 7 | 2002 | 101 | |
| 8 | 2001 | 82 | |
| 9 | 1995 | 65 | |
| 10 | 2001 | 55 | |
| 11 | 1996 | 39 | |
| 12 | 1987 | 37 | |
| 13 | 1997 | 36 | |
| 14 | 2015 | 33 | |
| 15 | 1991 | 31 | |
| 16 | 1991 | 30 | |
| 17 | 1997 | 30 | |
| 18 | 1997 | 30 | |
| 19 | 2017 | 27 | |
| 20 | 1990 | 27 |
About Mark S. Warren
Mark S. Warren is a scholar working on Molecular Biology, Materials Chemistry, Oncology, Molecular Medicine and Biochemistry, having authored 34 papers that have together received 2.4k indexed citations. Recurring topics across this work include Enzyme Structure and Function (12 papers), Biochemical and Molecular Research (8 papers), Drug Transport and Resistance Mechanisms (8 papers), Antibiotic Resistance in Bacteria (7 papers), Amino Acid Enzymes and Metabolism (5 papers), Pharmacological Effects and Toxicity Studies (3 papers), Bacterial Genetics and Biotechnology (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). The work is most often cited by research in Molecular Medicine (1.0k citations), Endocrinology (162 citations), Pharmacology (447 citations), Applied Microbiology and Biotechnology (41 citations) and Molecular Biology (1.3k citations). Mark S. Warren has collaborated with scholars based in United States and Japan. Frequent co-authors include Olga Lomovskaya, Hiroko Ishida, Kazuki Hoshino, Suzanne Chamberland, Elizabeth E. Howell, Ving J. Lee, Anita R. Mistry, Stephen J. Benkovic, Angela Lee and Jorge L. Galazzo. Their work appears in journals such as Biochemistry, Bioorganic & Medicinal Chemistry, Antimicrobial Agents and Chemotherapy, Drug Metabolism and Disposition and Molecular Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.